Picture of CorMedix logo

CRMD — CorMedix News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Brief: CorMedix Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 25 (Reuters) - CorMedix Inc CRMD.O:

CORMEDIX Q4 BASIC EPS USD 0.22

CORMEDIX Q4 NET INCOME USD 13.5 MILLION

CORMEDIX Q4 OPERATING EXPENSES USD 17.1 MILLION

CORMEDIX INC - TO COMMENCE PHASE 3 STUDY OF DEFENCATH IN Q2 2025

CORMEDIX INC - PRELIM NET REVENUE GUIDANCE FOR H1 2025 $50 MILLION - $60 MILLION

Source text: ID:nGNX6Kw1Nk

Further company coverage: CRMD.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on CorMedix

See all news